CDMO News
PolyPeptide Group Begins Large-Scale SPPS Production at Belgian Facility
PolyPeptide Group AG , a global CDMO specialising in peptide-based active pharmaceutical ingredients, has announced the commencement of production at its newly commissioned solid-phase peptide synthesis (SPPS) capacity in Braine-l’Alleud, Belgium. The €100 million facility represents the largest single investment
20 December 2024